Workplace vaccination against influenza in Malaysia: Does the employer benefit?

Journal of Occupational Health

Volumn 48, Issue 1, 2006, Pages 1-10

  Samad, Abu H ^a   Usul, Mohd H B H J ^b   Zakaria, Dalilah ^a   Ismail, Raman ^a   Tasset Tisseau, Anne ^c   Baron Papillon, Florence ^d   Follet, Alain ^d  

^a Menara Exxon ^*  (Malaysia)

^b PETRONAS CARIGALI SDN BHD   (Malaysia)

^c SANOFI PASTEUR   (France)

^d MAPI VALUES   (United States)

Author keywords

Cost benefit; Influenza; Occupational health; Vaccination

Indexed keywords

INFLUENZA VACCINE;

ABSENTEEISM; ADULT; ARTICLE; CHILL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; COUGHING; DEMOGRAPHY; DRUG HYPERSENSITIVITY; ECONOMIC ASPECT; EMPLOYEE; EMPLOYER; FATIGUE; FEMALE; FEVER; FINANCIAL MANAGEMENT; FLU LIKE SYNDROME; HEADACHE; HEALTH; HOARSENESS; HUMAN; INCOME; INFLUENZA; INFLUENZA VACCINATION; INJECTION SITE REACTION; INJECTION SITE SWELLING; MAJOR CLINICAL STUDY; MALAYSIA; MALE; MEDICAL INFORMATION; MEDICAL LEAVE; MYALGIA; PAIN; PETROCHEMICAL INDUSTRY; PRODUCTIVITY; PRURITUS; QUESTIONNAIRE; RESPIRATORY TRACT DISEASE; RHINORRHEA; SORE THROAT; SYSTEMIC DISEASE; VACCINATION; WORKPLACE;

ADULT; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; INFLUENZA, HUMAN; MALAYSIA; MALE; PROSPECTIVE STUDIES; WORKPLACE;

EID: 33644537027     PISSN: 13419145     EISSN: 13419145     Source Type: Journal    
DOI: 10.1539/joh.48.1     Document Type: Article

References (30)

1. Kilbourne ED, Arden NH. Inactivated influenza vaccines. In: Plotkin SA, Orenstein WA, eds. Vaccines, 3rd ed. Philadelphia, WB Saunders Company, 1999: 531-551.
2. N Shahidah, I Merican and R Ismail: Influenza surveillance in Malaysia: 1997-2001. MJPHM 3, 11-15 (2003)
3. RN Anderson and BL Smith: Deaths: leading causes for 2001. NVSS 52 (2003) (http://www.cdc.gov/nchs/ data/nvsr/nvsr52/nvsr52_09.pdf, accessed October 2004)
4. M Keech, AJ Scott and PJJ Ryan: The impact of influenza and influenza-like illness on productivity and healthcare resource utilization in a working population. Occup Med 48, 85-90 (1998)
5. KL Nichol, A Lind, KL Margolis, M Murdoch, R McFadden, M Hauge, S Magnan and M Drake. The effectiveness of vaccination against influenza in healthy working adults. N Engl J Med 333, 889-893 (1995)
6. Nicholson KG. Human Influenza. In: Nicholson KG, Webster RG, Hay AJ, eds. Textbook of Influenza. London, Blackwell Science Ltd, 1998: 222-264.
7. GW Olsen, JM Burris, MM Burlew, ME Steinberg, NV Patz, JA Stoltzfus and JH Mandel: Absenteeism among employees who participated in a workplace influenza immunization program. J Occup Environ Med 40, 311-316 (1998)
8. FW O'Reilly and AB Stevens: Sickness absence due to influenza. Occup Med 52, 265-269 (2002)
9. SL Shamansky: Presenteeism... or when being there is not being there. Pub Health Nurs 19, 79-80 (2002)
10. WP Glezen: Control of influenza. Tex Heart Inst J 31, 39-41 (2004)
11. A Morales, MM Martinez, A Tasset-Tisseau, E Rey, F Baron-Papillon and A Follet : Costs and benefits of influenza vaccination and work productivity in a Colombian company from the employer's perspective. Value Health 7, 433-441 (2004)
12. Food and Drug Administration (FDA): A look at the 2003-2004 flu season. FDA Consumer Magazine March-April (2004) (http://www.fda.gov/fdac/ 204_toc.html, accessed August 2004)
13. DM Fleming: The management of influenza in people of working age. Occup Med 52, 259-263 (2002)
14. K Stohr: Preventing and treating influenza. BMJ 326, 1223-1224 (2003)
15. J Beach and J Hobson: Editoral: influenza vaccination. Occup Med 52, 237-238 (2002)
16. MM Davis, SR McMahon, JM Santoli, B Schwartz and SJ Clark: A national survey of physician practices regarding influenza vaccine. J Gen Intern Med 17, 670-676 (2002)
17. S Stewart, SB Murray and SA Skull: Evaluation of healthcare worker vaccination in a tertiary Australian hospital. Int Med J 32, 585-592 (2002)
18. J Beran and J Moravik: Effectiveness of vaccination against influenza in SkodaAuto Company employees during the influenza season 2000-2001. Cent Eur J Public Health 11, 209-212 (2003)
19. KL Nichol, KP Mallon and PM Mendelman: Cost benefit of influenza vaccination in healthy, working adults: an economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine. Vaccine 21, 2207-2217 (2003)
20. V Demicheli, D Rivetti, J Deeks and T Jefferson: Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev. 4, CD001269 (2001)
21. M Koopmanschap, A Burdorf, K Jacob, WJ Meerding, W Brouwer and H Severens: Measuring productivity changes in economic evaluation: setting the research agenda. Pharmacoeconomics 23, 47-54 (2005)
22. KL Nichol: Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza. Arch Intern Med 161, 749-759 (2001)
23. CB Bridges, WW Thompson, MI Meltzer, GR Reeve, WJ Talamonti, NJ Cox, HA Lilac, H Hall, A Klimov and K Fukuda: Effectiveness and cost-benefit of influenza vaccination of healthy working adults. A randomised controlled trial. JAMA 284, 1655-1663 (2000)
24. E Burckel, T Ashraf, JP de Sousa Filho, E Forleo Neto, H Guarino, C Yauti, F de B Barreto and L Champion: Economic impact of providing workplace influenza vaccination. A model and case study application at a Brazilian pharma-chemical company. Pharmacoeconomics16, 563-576 (1999)
25. JH Dille: A worksite influenza program. Impact on lost work days, health care utilization, and health care spending. AAOHN Journal 47, 301-309 (1999)
26. PY Lee, DB Matchar, DA Clements, J Huber, JD Hamilton and ED Peterson: Economic analysis of influenza vaccination and antiviral treatment for healthy working adults. Ann Intern Med 137, 225-231 (2002)
27. KL Nichol: Clinical effectiveness and cost effectiveness of influenza vaccination among healthy working adults. Vaccine 17, S67-S73 (1999)
28. JA Wilde, JA McMillan, J Serwint, J Butta, MA O'Riordan and MC Steinhoff: Effectiveness of influenza vaccine in health care professionals. JAMA 281, 908-913 (1999)
29. DS Campbell and MH Rumley: Cost effectiveness of the influenza vaccine in a healthy working age population. J Occup Environ Med 39, 408-414 (1997)
30. P Cohen, C Darling, AW Hampson, K Downs and A Tasset-Tisseau: Influenza vaccination in an occupational setting: effectiveness and cost-benefit study. J Occup Health Safety (Aust, NZ) 19, 167-182 (2003)